Stay updated on Nivolumab and Relatlimab in Melanoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab and Relatlimab in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab and Relatlimab in Melanoma Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Added related topic links for Melanoma and MedlinePlus Genetics on the Study Details page.
    Difference
    0.2%
    Check dated 2026-02-21T03:51:04.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.4.2 and removed Revision: v3.4.1 along with the topics Melanoma and related topics: MedlinePlus Genetics; these are metadata updates and do not affect the study details. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-02-13T17:39:41.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The page adds a melanoma topic tag, related topics: MedlinePlus Genetics, and revision v3.4.1 (replacing v3.4.0); these metadata updates do not alter the study content, eligibility criteria, or reported outcomes, and to avoid alerts for small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-02-06T11:33:40.000Z thumbnail image
  4. Check
    19 days ago
    Change Detected
    Summary
    The page adds a Melanoma label and MedlinePlus Genetics related topics, and updates the revision badge to v3.4.1 (removing v3.4.0).
    Difference
    0.2%
    Check dated 2026-02-05T12:23:09.000Z thumbnail image
  5. Check
    27 days ago
    Change Detected
    Summary
    The changes are minor UI and metadata updates: a Show glossary option was added, QC-related labels such as Last Update Submitted that Met QC Criteria and release notes (Revision: v3.4.0; No FEAR Act Data) were introduced, while some related topics and older revision notes (e.g., MedlinePlus Genetics, Revision: v3.3.4) were removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-01-29T06:18:14.000Z thumbnail image
  6. Check
    34 days ago
    Change Detected
    Summary
    Melanoma is now listed as a related topic and a MedlinePlus Genetics link has been added under related topics.
    Difference
    0.2%
    Check dated 2026-01-22T03:31:11.000Z thumbnail image

Stay in the know with updates to Nivolumab and Relatlimab in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab and Relatlimab in Melanoma Clinical Trial page.